DANIELLE RICHARDS: Open Payments
NPI 1780842559 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 18 payments from 10 companies in 2025. Trend: 2023 $67 · 2024 $92 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $78 |
| PFIZER INC. | 3 | $69 |
| Lilly USA, LLC | 3 | $51 |
| Davol Inc. | 1 | $49 |
| ConvaTec Inc. | 1 | $33 |
| Novo Nordisk Inc | 2 | $31 |
| Ascensia Diabetes Care Us Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $15 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, ARISTA, ELIQUIS, INNOVAMATRIX AC, PREVNAR 20, SHINGRIX, OTEZLA.
Industry payments across MI — which companies pay providers there.
